Navigation Links
BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
Date:2/26/2008

INDIANAPOLIS, Feb. 26 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), announces the appointment of Dr. Wolfgang Hoffer as Managing Director of the company's European operations in Griesheim, Germany. Hoffer joins BST with nearly 20 years of management experience in the fields of clinical pharmacology and toxicology. In his new role, Hoffer will report directly to James M. Saponaro, Chief Operating Officer for BST, and will manage all aspects of BST's Europe Division, including sales and marketing, operations and finance.

Dr. Hoffer has previously held positions with MOMENTUM Pharma Services, MDS Pharma Services, PAREXEL(R) International, The Boston Consulting Group and Solvay Pharma. Most recently, he was site director of MOMENTUM Pharma Services' Hamburg, Germany, location, following its spinout from MDS Pharma Services.

"Hoffer will focus on offering worldwide service to our global pharmaceutical clients while maintaining our standards of operational excellence," said F. John Mills, M.D., Ph.D., Chief Executive Officer and Chairman of the Board.

"We were looking for someone with broad, credible experience in the pharmaceutical and contract research industry. Not only does Wolfgang have the right level of industry experience and credentials, but he also has a first- rate, entrepreneurial spirit. We wanted someone who is willing to roll up his sleeves and get things done, and he is definitely that kind of individual," said Mills.

Dr. Hoffer holds a doctorate in physiological chemistry from the University of Veterinary Medicine Hannover (Germany), and is a certified veterinarian in the German state of Bavaria. Dr. Hoffer began his educational career studying chemistry and biology at the University of Kaiserslautern (Germany).

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a worldwide leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries throughout the research, clinical trial and commercialization phases of drug development. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full- service site near Frankfurt, Germany. For more information about the company, please visit http://www.biostorage.com or call +1 (866) 697-2675 or +49 615 582 4490.


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Appoints Lori Ball as Vice President
2. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. NASA MidSTAR-1 successful technologies may be revolutionary
8. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
9. Neurobiological Technologies Sets Date for Research and Development Day
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
11. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
Breaking Biology News(10 mins):